Vir Biotechnology

YTD

ALL

Trade Vir Biotechnology 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VIR

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.

CEO

Marianne de Backer

CEOMarianne de Backer

Employees

408

Employees408

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2016

Founded2016

Employees

408

Employees408

VIR Key Statistics

Market cap

817.37M

Market cap817.37M

Price-Earnings ratio

-1.56

Price-Earnings ratio-1.56

Dividend yield

—

Dividend yield—

Average volume

1.10M

Average volume1.10M

High today

$6.22

High today$6.22

Low today

$5.93

Low today$5.93

Open price

$6.11

Open price$6.11

Volume

1.11M

Volume1.11M

52 Week high

$14.45

52 Week high$14.45

52 Week low

$4.95

52 Week low$4.95

Analyst ratings

78%

of 9 ratings

Buy

77.8%

Hold

22.2%

Sell